These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27241574)

  • 21. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.
    Murdock RC; Braydich-Stolle L; Schrand AM; Schlager JJ; Hussain SM
    Toxicol Sci; 2008 Feb; 101(2):239-53. PubMed ID: 17872897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization of pluripotent stem cell cultures for toxicity testing.
    Pistollato F; Bremer-Hoffmann S; Healy L; Young L; Stacey G
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):239-57. PubMed ID: 22248265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
    McGivern JV; Ebert AD
    Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospects and Frontiers of Stem Cell Toxicology.
    Liu S; Yin N; Faiola F
    Stem Cells Dev; 2017 Nov; 26(21):1528-1539. PubMed ID: 28874109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing health risks of inhaled nanomaterials: development of pulmonary bioassay hazard studies.
    Warheit DB
    Anal Bioanal Chem; 2010 Sep; 398(2):607-12. PubMed ID: 20665009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative lung toxicity of engineered nanomaterials utilizing in vitro, ex vivo and in vivo approaches.
    Kim YH; Boykin E; Stevens T; Lavrich K; Gilmour MI
    J Nanobiotechnology; 2014 Nov; 12():47. PubMed ID: 25424549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Bayesian networks for hazard ranking of nanomaterials to support human health risk assessment.
    Marvin HJ; Bouzembrak Y; Janssen EM; van der Zande M; Murphy F; Sheehan B; Mullins M; Bouwmeester H
    Nanotoxicology; 2017 Feb; 11(1):123-133. PubMed ID: 28044458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.
    Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM
    Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening.
    Greenhough S; Medine CN; Hay DC
    Toxicology; 2010 Dec; 278(3):250-5. PubMed ID: 20674645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-throughput screen for teratogens using human pluripotent stem cells.
    Kameoka S; Babiarz J; Kolaja K; Chiao E
    Toxicol Sci; 2014 Jan; 137(1):76-90. PubMed ID: 24154490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem Cells, a New Generation Model for Predictive Nano Toxicological Assessment.
    Suma RN; Mohanan PV
    Curr Drug Metab; 2015; 16(10):932-9. PubMed ID: 26467070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives of future lung toxicology studies using human pluripotent stem cells.
    Masui A; Hirai T; Gotoh S
    Arch Toxicol; 2022 Feb; 96(2):389-402. PubMed ID: 34973109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials.
    Pal AK; Bello D; Cohen J; Demokritou P
    Nanotoxicology; 2015; 9(7):871-85. PubMed ID: 25672815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nano-bio effects: interaction of nanomaterials with cells.
    Cheng LC; Jiang X; Wang J; Chen C; Liu RS
    Nanoscale; 2013 May; 5(9):3547-69. PubMed ID: 23532468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of nanotoxicology: implications for drug delivery and medical devices.
    Bhattacharjee S; Brayden DJ
    Nanomedicine (Lond); 2015 Jul; 10(14):2289-305. PubMed ID: 26114880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.